Tolerability and efficacy of benazepril in cats with chronic kidney disease

Journal of Veterinary Internal Medicine

Volumn 20, Issue 5, 2006, Pages 1054-1064

  King, Jonathan N ^a   Gunn Moore, Danielle A ^b,d   Tasker, Séverine ^c   Gleadhill, Allison ^d   Strehlau, Günther ^a   Ash, R A ^d   Bussadori, C ^d   Bonfanti, U ^d   Papadopulo, I ^d   Santilli, S ^d   Ghibaudo, G ^d   Lanore, D ^d   Clarke, D D ^d   Gleadhill, A ^d   Mackin, A ^d   Tasker, S ^d   Varga, K ^d   Cotard, J P ^d   Jacquemin, N ^d   Crowe, I D ^d   Rousselot, J F ^d   Stonton, S A ^d   De Geyer, G ^d   Dossin, O ^d   Hagege, G ^d   Arthur, J ^d   Brovida, C ^d   Pechereau, D ^d   Martel, P ^d   Closa, J M ^d   Font, A ^d   Laforge, H ^d   Piette, M H ^d   Do Chi, T ^d   more..

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d NONE

Author keywords

ACE inhibitor; Appetite; Plasma protein; Proteinuria; Survival time; Urine protein to creatinine ratio

Indexed keywords

EID: 33750313438     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2006)20[1054:TAEOBI]2.0.CO;2     Document Type: Article

References (27)

1. Barber P. Diagnosis and management of chronic renal failure in the cat. In Pract 2003;25:306-313.
2. Elliot J, Brown SA. Renal Diseases in the Dog and Cat. Faringdon, Oxon, UK; Nova Professional Media Ltd; 2004.
3. Maschio G, Alberti D, Janin G, et al. Effect of the angiotensin- converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996;334:939-945.
4. Locatelli F, Carbarns IRI, Maschio G, et al. Long-term progression of chronic renal insufficiency in the AIPRI extension study. Kidney Int 1997;52(Suppl):S63-S66.
5. The GISEN Group (Gruppo Italiano Studi Epidemiologica in Nephrologia). Randomized, placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and progression to terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997;349:1857-1863.
6. Brown SA, Brown CA, Jacobs G, et al. Effects of the angiotensin- converting-enzyme inhibitor benazepril in cats with induced renal insufficiency. Am J Vet Res 2001;62:375-383.
7. Brown SA, Finco DR, Brown CA, et al. Evaluation of the effects of inhibition of angiotensin converting enzyme with enalapril in dogs with induced chronic renal insufficiency. Am J Vet Res 2003;64:321-327.
8. Brown SA, Walton CL, Crawford P, et al. Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria. Kidney Int 1993;43:1210-1218.
9. Grauer G, Greco D, Gretzy D, et al. Effects of enalapril treatment versus placebo as a treatment for canine idiopathic glomerulonephritis. J Vet Int Med 2000;14:526-533.
10. Anderson S, Meyer TW, Rennke HG, et al. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985;76:612-619.
11. Remuzzi A, Puntorieri S, Battaglia C, et al. Angiotensin converting-enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 1990;85:541-549.
12. Takahara S, Moriyama T, Kokado Y, et al. Randomized prospective study of effects of benazepril in renal transplantation: An analysis of safety and efficacy. Clin Exp Nephrol 2002;6:242-247.
13. Knight D. Pathophysiology of heart failure and clinical evaluation of cardiac function. In: Ettinger SJ, ed. Textbook of Veterinary Internal Medicine, 4th ed. Philadelphia, PA: WB Saunders, 1995:844-867.
14. King JN, Humbert-Droz E, Maurer M. Plasma angiotensin converting enzyme activity and pharmacokinetics of benazepril and benazeprilat in cats after single and repeated oral administration of benazepril-HCl. J Vet Pharmacol Ther 1999;22:360-367.
15. Narayanan S, Appleton HD. Creatinine: A review. Clin Chem 1980;26:1119-1126.
16. The BENCH Study Group. The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: Results of a multi-center, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial. J Vet Cardiol 1999;1:7-18.
17. Kvart C, Haggstrom J, Pederson HD, et al. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation. J Vet Intern Med 2002;16:80-88.
18. Jafar TH, Stark PC, Schmid CH, et al. Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int 2001;60:1131-1140.
19. Ruggenenti P, Perna A, Remuzzi G, et al. Retarding progression of chronic renal disease: The neglected issue of residual proteinuria. Kidney Int 2003;63:2254-2261.
20. Praga M, Morales E. Renal damage associated with proteinuria. Kidney Int 2002;62:42-46.
21. Ruggenenti P, Perna A, Remuzzi G. ACE inhibitors to prevent end-stage renal disease: When to start and why possibly never to stop: A post hoc analysis of the REIN trial results. J Am Soc Nephrol 2001;12:2832-2837.
22. Elliot J, Barber PJ, Syme HM, et al. Feline hypertension: Clinical findings and response to antihypertensive therapy in 30 cats. J Small Anim Pract 2000;42:122-129.
23. Snyder PS, Sadek D, Jones GL. Effect of amlodipine on echocardiographic variables in cats with systemic hypertension. J Vet Intern Med 2001;15:52-56.
24. King JN, Seewald W, King S, et al. Benazepril increases feed intake and body weight in healthy growing cats. J Vet Pharmacol Ther 2006;29:225-227.
25. Anker SD, Negassa A, Coats AJS, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting enzyme inhibitors: An observational study. Lancet 2003;361:1077-1083.
26. Gennari FJ, Segal AS. Hyperkalemia: An adaptive response in chronic renal insufficiency. Kidney Int 2002;62:1-9.
27. Brown SA, Crowell WA, Brown CA, et al. Pathophysiology and management of progressive renal disease. Br Vet J 1997;154:93-109.